Original Research
Accepted on 18 Apr 2025
Adherence and Persistence with Istradefylline Treatment in Patients with Parkinson's Disease in the United States
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1548631
26,200 Publications
Volume 16 - 2025
Editorial
Accepted on 18 Apr 2025
Editorial: Integrative Pharmacological Approaches for Regenerating Cartilage and Bone Tissue
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613512
Original Research
Accepted on 18 Apr 2025
Compatibility optimization of the traditional Chinese medicines 'Eczema mixture' based on Back-Propagation Artificial Neural Network and Non-dominated Sorting Genetic Algorithm
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1593783
Original Research
Accepted on 18 Apr 2025
Albiflorin inhibits inflammation to improve liver fibrosis by targeting the CXCL12/CXCR4 axis in mice
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1577201
Original Research
Accepted on 18 Apr 2025
The impact of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin dose requirement in Saudi patients
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1547142
Review
Accepted on 18 Apr 2025
Curcumin: A potential anti-photoaging agent
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559032
Original Research
Accepted on 18 Apr 2025
Beta-boswellic Acid Facilitates Diabetic Wound Healing by Targeting STAT3 and Inhibiting Ferroptosis in Fibroblasts
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578625
Original Research
Accepted on 18 Apr 2025
Adverse drug events associated with Insulin glargine: a real-world pharmacovigilance study based on the FAERS database
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563238
Review
Accepted on 18 Apr 2025
The research progress on radionuclides in osteoporosis diagnosis and drug efficacy monitoring
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1594903
Original Research
Accepted on 18 Apr 2025
Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1520771
Original Research
Accepted on 18 Apr 2025
Gen-miR-5 Derived from Gentianella acuta Inhibits PFKP to Prevent Fibroblast Activation and Alleviate Myocardial Fibrosis
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578877
Review
Accepted on 18 Apr 2025
Gut Microbiota: A New Target for the Prevention and Treatment of Insomnia Using Chinese Herbal Medicines and Their Active Components
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1572007
Review
Accepted on 18 Apr 2025
Pharmacological Potential of Natural Chalcones: A Recent Studies and Future Perspective
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1570385
Original Research
Accepted on 18 Apr 2025
Harmine derivative B-9-3 inhibits non-small cell lung cancer via the VEGFA/PI3K/AKT pathway
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1526952
Original Research
Accepted on 18 Apr 2025
Bioactive Lipids and Allelopathic Potential of the Invasive Plant Heracleum sosnowskyi: Insights into Its Fatty Acid Composition, Antimicrobial and Cytotoxic Effects
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1582694
Original Research
Accepted on 18 Apr 2025
Serum 25(OH)D and plasma fatty acids on breast and gastric tumors: A cross-sectional study in Northeast China
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1567568